Advertisement
Advertise here Publish your press releases here Sponsor BioPortfolio
Follow us on Twitter Sign up for daily news and research emails Contributors wanted

Raynaud's Syndrome - Biotech, Pharma and Life Science Channel

19:53 EDT 24th April 2014 | BioPortfolio

PubMed Articles [4208 Associated PubMed Articles listed on BioPortfolio]

Aspirin Desensitization: Useful Treatment for Chronic Rhinosinusitis with Nasal Polyps (CRSwNP) in Aspirin-Exacerbated Respiratory Disease (AERD)?

Aspirin intolerance syndrome is due to disturbances in the arachidonic acid metabolism implicating both the lipoxygenase and cyclooxygenase pathways. This results in imbalances of eicosanoid, leukotri...

Good's Syndrome, CVID, and Selective Antibody Deficiency in Patients with Chronic Rhinosinusitis.

Good's syndrome and common variable immune deficiency (CVID) are associated with chronic rhinosinusitis. Good's syndrome is characterized by hypogammaglobulinemia, B-cell depletion, variable defects i...

Influence of dietary pattern, physical activity, and I148M PNPLA3 on steatosis severity in at-risk adolescents.

Evidence relating dietary patterns to obesity and related disorders such as non-alcoholic fatty liver disease (NAFLD) is limited in pediatric age. Aim of this study was to analyze the association betw...

Platelet function testing in contemporary clinical and interventional practice.

Dual antiplatelet therapy with a combination of aspirin and an inhibitor of the ADP P2Y12 receptor is the recommended treatment for patients with acute coronary syndrome or who are undergoing percutan...

Management of hyponatremia in clinical hepatology practice.

The burden of liver disease continues to increase in the United States, with the epidemics of hepatitis C, alcoholic liver disease, and the coming wave of nonalcoholic fatty liver disease patients all...

Anti-epileptic drugs and hormonal treatments.

Epilepsy and the medications used in its treatment are known to affect the menstrual cycle, aspects of contraception, and bone health in women. Adolescence is an important time to review the diagnosis...

Development of Evidenced-Based Guidelines for PCOS and Implications for Community Health.

Despite the prevalence and health implications of polycystic ovary syndrome (PCOS), key evidence practice gaps exist including delayed diagnosis, inconsistent management, inadequate support for lifest...

Menopausal implications of polycystic ovarian syndrome.

Polycystic ovary syndrome (PCOS) is a common endocrinopathy affecting up to 8 to 10% of reproductive-aged women. Although the medical and metabolic consequences of PCOS are well-described in young rep...

Treatment of polycystic ovary syndrome in adolescence.

Adolescence is a time of rapidly changing reproductive hormones and menstrual patterns making diagnosis of polycystic ovary syndrome (PCOS) challenging in this population. Nonetheless, there is signif...

Childhood Obesity and Its Impact on the Development of Adolescent PCOS.

Obesity exacerbates the reproductive and metabolic manifestations of polycystic ovary syndrome (PCOS). The symptoms of PCOS often begin in adolescence, and the rising prevalence of peripubertal obesit...

News Articles [1301 Associated News Articles listed on BioPortfolio]

A New Lamin A Mutation Associated with Acrogeria Syndrome

Natera Receives Conditional Approval from New York State Department of Health for Panorama™ NIPT with 22q11.2 Deletion Syndrome

Natera, Inc., a leading innovator in prenatal genetic testing, today announced that it has received a new conditional approval from the New York State Department of Health to offe...

Catalyst starts process to offer Firdapse at no cost to LEMS patients in US

US-based Catalyst Pharmaceutical Partners has initiated the process necessary to establish an expanded access program (EAP) to make available its investigational potassium channel inhibitor, Firdapse...

Expanding the clinical spectrum of B4GALT7 deficiency: homozygous p.R270C mutation with founder effect causes Larsen of Reunion Island syndrome

Nine Cases of MERS-CoV are Reported to WHO

The Ministry of Health of the United Arab Emirates (UAE) has reported to the World Health Organization (WHO) an additional nine laboratory-confirmed cases of infection with Middle East respiratory syn...

Catalyst Announces Initiation of an Expanded Access Program to Provide Firdapse at No Cost to U.S. Patients with Lambert-Eaton Myasthenic Syndrome

Catalyst Pharmaceutical Partners, Inc. announced today it has begun the process required to establish an expanded access program (EAP) to make available in the United States its i...

Normal-Tension Glaucoma and Obstructive Sleep Apnea Syndrome

What does obstructive sleep apnea have to do with glaucoma? This new study investigates the possible connection. BMC Ophthalmology

Contributions of a 'sorting nexin' protein to learning impairments in Down's syndrome

Every year, roughly 1 in 1,000 children worldwide are born with Down's syndrome. This developmental disorder, associated with potentially severe intellectual and learning disabilities among other char...

The Pinnacle Schools Celebrates Autism Awareness Month

The Pinnacles Schools Elk River Treatment Program recognize the Karkut family during Autism Awareness Month. Huntsville, AL (PRWEB) April 23, 2014 April is Autism Awareness Month but for Jeff and Nan...

Acute Respiratory Distress Syndrome - Pipeline Review, H1 2014

Recently added to the BioPortfolio report store, Acute Respiratory Distress Syndrome - Pipeline Review, H1 2014 is a new report from Global Markets Direct published on 2014-03-30. This 79-page report...

Events [0 Results]

None

Companies [44 Associated Companies listed on BioPortfolio]

Catalyst Pharmaceutical Partners, Inc.

Catalyst Pharmaceutical Partners, Inc. is a specialty pharmaceutical company focused on the development and commercialization of prescription drugs targeting rare (orphan) neuromu...

Akebia Therapeutics, Inc.

Akebia Therapeutics is a discovery and development company focused on anemia and vascular disorders. Akebia’s lead program, AKB-6548, an orally bioavailable HIF-prolyl hydrox...

XenoPort

We are a biopharmaceutical company focused on developing a portfolio of internally discovered product candidates for the potential treatment of central nervous system (CNS) disorders. We also have a p...

NPS Pharmaceuticals

NPS Pharmaceuticals is engaged in the discovery, development and commercialization of therapeutic small molecules and recombinant proteins to treat bone and mineral, gastrointestinal and central nervo...

My Possibilities

My Possibilities is a Plano, Texas-based non-profit, charity - 501(c)(3), for adults with disabilities (Autism, Down Syndrome, Aspergers, Prader-Willi, Head Injuries, etc.). St...

Sea-licious™

Karlene Karst, a Registered Dietician, is a leading health specialist in both nutrition and natural medicine. She is the co-author of the national best seller “Healthy...

Novaliq GmbH

"Novaliq GmbH is a medical technology / biopharmaceutical company with the aim to develop and market life-saving drug delivery systems for the treatment of severe lung diseases, such as for example ac...

Synergy Pharmaceuticals Inc.

Synergy Pharmaceuticals, Inc. is a biopharmaceutical company focused on the development of new drugs to treat patients with gastrointestinal (GI) diseases and disorders. Synergyâ...

Avaxia Biologics, Inc.

Avaxia is a leader in the growing field of gut-targeted therapeutics — orally administered, minimally absorbed drugs that are designed to act locally in the gastrointestinal...

Sturge-Weber Foundation

Since its founding in 1987, the Sturge-Weber Foundation (SWF) has provided information, education and friendly support to adults and families of children with Sturge-Weber syndrom...

Clinical Trials [1806 Associated Clinical Trials listed on BioPortfolio]

Safety and Pharmacokinetics of Ifetroban in Hepatorenal Syndrome Patients

Cumberland Pharmaceuticals Inc. (CPI) is developing ifetroban for treatment of hepatorenal syndrome (HRS) and proposes to conduct a study in hospitalized adult patients with HRS to assess...

MAESTRO-OL: Macitentan in Eisenmenger Syndrome To Restore Exercise Capacity (Open-Label)

Long-term study to evaluate if macitentan is safe, tolerable and efficient enough to be used for treatment of Eisenmenger syndrome.

Guanfacine in Children With Tic Disorders

The goal of this pilot study is to obtain preliminary information on the tolerability and efficacy of extended release guanfacine (trade name Intuniv) in children with Tourette Disorder (T...

Survey of Patients With Idiopathic Orbital Inflammation Syndrome

The purpose of this study is to characterise the clinical features, histopathology and the treatment outcomes of patients with idiopathic orbital inflammation syndrome.

Randomized Study of ON 01910.Na in Refractory Myelodysplastic Syndrome Patients With Excess Blasts

The primary objective of this study is to compare overall survival (OS) in patients receiving ON 01910.Na + best supportive care (BSC) to OS of patients receiving BSC in a population of pa...

Observational Study to Investigate the Effectiveness of Eprosartan on Pulse Pressure (Teveten_MS)

The study is to identify the effectiveness of Eprosartan on pulse pressure in hypertensive patients with metabolic syndrome -Definition of pulse pressure (PP): Difference between systolic...

Efficacy of Mesalamine in Diarrhea-predominant Irritable Bowel Syndrome (dIBS)

The purpose of this study is to find whether treating patients with diarrhea predominant Irritable Bowel Syndrome (IBS) with an anti-inflammatory drug called Mesalamine will help improve t...

Efficacy of Minoxidil in Children With Williams-Beuren Syndrome

The Williams-Beuren syndrome (WBS) is a sporadic congenital disorder characterized by a multisystem developmental impairment. This syndrome is caused by a microdeletion in chromosome 7q11....

Sleep Disordered Breathing and Impaired Glucose Homeostasis in Obese Children

SDB has been identified as an important risk factor for insulin resistance and the metabolic syndrome. In a recent study in patients with SDB and T2DM it was shown that CPAP therapy can l...

Pre-Transplant 5-Azacitidine In Patients With High-Risk Myelodysplastic Syndrome Who Are Candidates For Allogeneic Hematopoietic Cell Transplant

The purpose of this study is to find out if treating people who have high-risk myelodysplastic syndrome (MDS) with Vidaza (also called 5-azacitidine) prior to their allogeneic hematopoieti...

Medical and Biotech [MESH] Definitions

An idiopathic vascular disorder characterized by bilateral Raynaud phenomenon, the abrupt onset of digital paleness or CYANOSIS in response to cold exposure or stress.

A mild form of LIMITED SCLERODERMA, a multi-system disorder. Its features include symptoms of CALCINOSIS; RAYNAUD DISEASE; ESOPHAGEAL MOTILITY DISORDERS; sclerodactyly, and TELANGIECTASIS. When the defect in esophageal function is not prominent, it is known as CRST syndrome.

A selective adrenergic alpha-1 antagonist used in the treatment of heart failure, hypertension, pheochromocytoma, Raynaud's syndrome, prostatic hypertrophy, and urinary retention.

A nonselective alpha-adrenergic antagonist. It is used in the treatment of hypertension and hypertensive emergencies, pheochromocytoma, vasospasm of RAYNAUD DISEASE and frostbite, clonidine withdrawal syndrome, impotence, and peripheral vascular disease.

A syndrome with overlapping clinical features of systemic lupus erythematosus, scleroderma, polymyositis, and Raynaud's phenomenon. The disease is differentially characterized by high serum titers of antibodies to ribonuclease-sensitive extractable (saline soluble) nuclear antigen and a "speckled" epidermal nuclear staining pattern on direct immunofluorescence.

Search BioPortfolio:
Advertisement
review and buy Raynaud's Syndrome market research data and corporate reports here

Channels Quicklinks

Advertisement